When the eight pathology departments with more than 3000 BC patients were considered separately, the frequency of score 0 ranged from 18.1 to 38.4% and the proportion of HER2-low cases from 49.2 to 70.0% (P < 0.0001 in both cases). The gene discussed is ERBB2; the disease is breast cancer.